Financials

News Discussions Technicals Seasonals

6696 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Lin BioScience, Inc. engages in the development of drugs. It offers medicines for acute leukemia, solid tumors, type 2 diabetes, glioblastoma, and stargardt disease. The company was founded by Yue Hsin Lin on May 12, 2016 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6696 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company